Literature DB >> 8576280

DNA ploidy level assessments in 83 human brain metastases. Relationship to the survival of 35 patients.

R Kiss1, S Rorive, I Camby, J L Pasteels, J Brotchi, I Salmon.   

Abstract

The nuclear DNA content (DNA ploidy) level was determined in a series of 83 human brain metastases, for which 35 complete clinical follow-ups were available. The DNA ploidy level determination was carried out by means of DNA histogram types. The results show that certain brain metastases were diploid, while others exhibited aneuploidy levels ranging from low to very high. The present study also shows that a significant proportion, i.e. 18%, of the 83 brain metastases, exhibited very high levels of aneuploidy, i.e. hypertetraploidy, hyperpentaploidy and octoploidy. We have previously observed that this feature appeared only rarely, i.e. in less than 2% of primary nervous tumours. Furthermore, the present study shows that DNA ploidy level in brain metastases is related significantly (P < 0.001) to patient survival. Indeed, while 9/13 (69%) patients with diploid brain metastases survived longer than 9 months, none (0%) of the 22 patients with aneuploid brain metastases survived longer than the 9 months following the diagnosis of their brain metastases.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8576280     DOI: 10.1007/bf01226271

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  25 in total

1.  17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy.

Authors:  P L Blount; P C Galipeau; C A Sanchez; K Neshat; D S Levine; J Yin; H Suzuki; J M Abraham; S J Meltzer; B J Reid
Journal:  Cancer Res       Date:  1994-05-01       Impact factor: 12.701

2.  Resection for solitary brain metastasis. Role of adjuvant radiation and prognostic variables in 229 patients.

Authors:  S R Smalley; E R Laws; J R O'Fallon; E G Shaw; M F Schray
Journal:  J Neurosurg       Date:  1992-10       Impact factor: 5.115

3.  DNA histogram typing in a series of 707 tumors of the central and peripheral nervous system.

Authors:  I Salmon; A Kruczynski; I Camby; M Levivier; J L Pasteels; J Brotchi; R Kiss
Journal:  Am J Surg Pathol       Date:  1993-10       Impact factor: 6.394

4.  Modification of tumor ploidy level via the choice of tissue taken as diploid reference in the digital cell image analysis of Feulgen-stained nuclei.

Authors:  R Kiss; P Gasperin; A Verhest; J L Pasteels
Journal:  Mod Pathol       Date:  1992-11       Impact factor: 7.842

5.  Stabilised p53 facilitates aneuploid clonal divergence in colorectal cancer.

Authors:  P Carder; A H Wyllie; C A Purdie; R G Morris; S White; J Piris; C C Bird
Journal:  Oncogene       Date:  1993-05       Impact factor: 9.867

6.  Defining the role of radiosurgery in the management of brain metastases.

Authors:  M P Mehta; J M Rozental; A B Levin; T R Mackie; S S Kubsad; M A Gehring; T J Kinsella
Journal:  Int J Radiat Oncol Biol Phys       Date:  1992       Impact factor: 7.038

7.  DNA histogram typing in retinoblastomas and neuroblastomas.

Authors:  J M Dangou; I Salmon; L F Torres; V Budel; P D Ndiaye; J L Pasteels; A Verhest; R Kiss
Journal:  Mod Pathol       Date:  1993-07       Impact factor: 7.842

8.  Image cytometry determination of ploidy level, proliferative activity, and nuclear size in a series of 314 transitional bladder cell carcinomas.

Authors:  R van Velthoven; M Petein; W J Oosterlinck; C Zandona; A Zlotta; A P Van der Meijden; J L Pasteels; H Roels; C Schulman; R Kiss
Journal:  Hum Pathol       Date:  1995-01       Impact factor: 3.466

9.  Ploidy level and proliferative activity measurements in a series of 407 thyroid tumors or other pathologic conditions.

Authors:  I Salmon; P Gasperin; M Remmelink; I Rahier; P Rocmans; J L Pasteels; R Heimann; R Kiss
Journal:  Hum Pathol       Date:  1993-08       Impact factor: 3.466

10.  Epidemiology of brain tumors: the national survey of intracranial neoplasms.

Authors:  A E Walker; M Robins; F D Weinfeld
Journal:  Neurology       Date:  1985-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.